Details
| Stereochemistry | MIXED |
| Molecular Formula | C15H20ClN5.ClH |
| Molecular Weight | 342.267 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC1CCC2(CC1)N=C(N)N=C(N)N2C3=CC=C(Cl)C=C3
InChI
InChIKey=ZCZOXDNZEYCBRL-UHFFFAOYSA-N
InChI=1S/C15H20ClN5.ClH/c1-10-6-8-15(9-7-10)20-13(17)19-14(18)21(15)12-4-2-11(16)3-5-12;/h2-5,10H,6-9H2,1H3,(H4,17,18,19,20);1H
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/14184889
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14184889
Spirotriazine is a dihydrotriazine derivative patented by Burroughs Wellcome & Co. (U.S.A.) Inc. as the anthelmintic agent. In preclinical models, Spirotriazine shows potent activity against intestinal parasites and negligible microbiological activity.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C73817
Created by
admin on Mon Mar 31 18:10:37 GMT 2025 , Edited by admin on Mon Mar 31 18:10:37 GMT 2025
|
PRIMARY | |||
|
I4I0Q76VHJ
Created by
admin on Mon Mar 31 18:10:37 GMT 2025 , Edited by admin on Mon Mar 31 18:10:37 GMT 2025
|
PRIMARY | |||
|
73940-99-5
Created by
admin on Mon Mar 31 18:10:37 GMT 2025 , Edited by admin on Mon Mar 31 18:10:37 GMT 2025
|
PRIMARY | |||
|
DTXSID10224614
Created by
admin on Mon Mar 31 18:10:37 GMT 2025 , Edited by admin on Mon Mar 31 18:10:37 GMT 2025
|
PRIMARY | |||
|
3057054
Created by
admin on Mon Mar 31 18:10:37 GMT 2025 , Edited by admin on Mon Mar 31 18:10:37 GMT 2025
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD